- Home
- MRNA vs JBHT Comparison
MRNA vs JBHT Comparison
Compare MRNA & JBHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- JBHT
- Stock Information
- Founded
- MRNA 2010
- JBHT 1961
- Country
- MRNA United States
- JBHT United States
- Employees
- MRNA N/A
- JBHT N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- JBHT Trucking Freight/Courier Services
- Sector
- MRNA Health Care
- JBHT Industrials
- Exchange
- MRNA Nasdaq
- JBHT Nasdaq
- Market Cap
- MRNA 13.4B
- JBHT 14.4B
- IPO Year
- MRNA 2018
- JBHT N/A
- Fundamental
- Price
- MRNA $28.02
- JBHT $143.45
- Analyst Decision
- MRNA Hold
- JBHT Buy
- Analyst Count
- MRNA 20
- JBHT 19
- Target Price
- MRNA $46.24
- JBHT $168.58
- AVG Volume (30 Days)
- MRNA 8.6M
- JBHT 1.0M
- Earning Date
- MRNA 08-01-2025
- JBHT 07-15-2025
- Dividend Yield
- MRNA N/A
- JBHT 1.23%
- EPS Growth
- MRNA N/A
- JBHT N/A
- EPS
- MRNA N/A
- JBHT 5.51
- Revenue
- MRNA $3,078,000,000.00
- JBHT $12,064,092,000.00
- Revenue This Year
- MRNA N/A
- JBHT $1.38
- Revenue Next Year
- MRNA $10.04
- JBHT $5.32
- P/E Ratio
- MRNA N/A
- JBHT $26.03
- Revenue Growth
- MRNA N/A
- JBHT N/A
- 52 Week Low
- MRNA $23.15
- JBHT $122.79
- 52 Week High
- MRNA $91.99
- JBHT $200.40
- Technical
- Relative Strength Index (RSI)
- MRNA 46.33
- JBHT 47.68
- Support Level
- MRNA $25.30
- JBHT $142.17
- Resistance Level
- MRNA $27.08
- JBHT $146.07
- Average True Range (ATR)
- MRNA 1.33
- JBHT 3.34
- MACD
- MRNA -0.31
- JBHT 0.01
- Stochastic Oscillator
- MRNA 32.38
- JBHT 53.34
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About JBHT J.B. Hunt Transport Services Inc.
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (48% of sales), dedicated trucking services that provide customer-specific fleet needs (27%), for-hire truckload (6%), heavy goods final-mile delivery (7%), and asset-light truck brokerage (12%).